IP Verse

Zentiva patent opposition analysis

Get complete Patent Opposition Report for Zentiva

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Zentiva

Explore patent oppositions filed by Zentiva against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3090730Novel Pharmaceutical CompositionNOVARTISJan 10, 2025
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 14, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024
EP2825558Combination Therapy For The Treatment Of Ovarian CancerFHOFFMANN LA ROCHEAug 28, 2024
EP3626270New UseNOVARTISJul 11, 2024
EP4070788Pharmaceutical FormulationsGILEAD SCIENCESDec 11, 2023
EP3294283Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 8, 2023
EP4070787Pharmaceutical FormulationsGILEAD SCIENCESNov 29, 2023
EP2981255Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 12, 2022

Latest patents of Zentiva opposed by its competitors

Explore Zentiva's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3025705Nov 28, 2018Stable Ivabradine Formulations1

Top competitors of Zentiva